Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05884944 · ClinicalTrials.gov registry record · NA
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients
A NA study of Parkinson Disease and Osteopathy in Diseases Classified Elsewhere, sponsored by New York Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05884944 is a NA study of Parkinson Disease and Osteopathy in Diseases Classified Elsewhere that is actively recruiting participants, run by New York Institute of Technology. The registered enrollment target is 20 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05884944, a NA study of Parkinson Disease and Osteopathy in Diseases Classified Elsewhere, is actively recruiting participants, sponsored by New York Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the effects that Osteopathic Manipulative Medicine has on lower extremity muscle characteristics in PD. Muscle stiffness, range of motion, and gait will be measured. Participants will be asked to attend one in person session at the NYIT Academic Health Care Center. Participants will be randomly assigned to a control or experimental group. After a visit with the treating physician, both groups will have muscle stiffness tested using a myotonometry meter via a MyotonPRO device, gait measured while walking on a treadmill for 2 minutes before and after treatment, and range of motion tested using a goniometer. One week after the visit, participants will be asked to complete a brief survey over the phone with one of the study investigators.
Conditions Studied
Interventions
- PROCEDURE Sham- Light touch, not reaching restrictive barrier
- PROCEDURE Experimental: Interventional Group- OMM- Muscle energy
Study Locations (1)
New York
- NYIT College of Osteopathic Medicine - Old Westbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-07-06 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05884944
The ClinicalTrials.gov registry entry for NCT05884944 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Sham- Light touch, not reaching restrictive barrier is the first listed.
NCT05884944 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05884944 about?
NCT05884944 is a clinical study titled "Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients". The purpose of the study is to investigate the effects that Osteopathic Manipulative Medicine has on lower extremity muscle characteristics in PD. Muscle stiffness, range of motion, and gait will be measured. Participants will be asked to attend one in person session at the NYIT Academic Health Car...
What is the current status of trial NCT05884944?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-07-06. Estimated completion is 2025-12.
What conditions does trial NCT05884944 study?
This clinical trial studies the following conditions: Parkinson Disease, Osteopathy in Diseases Classified Elsewhere.
What interventions are being tested in trial NCT05884944?
The interventions under investigation include: Sham- Light touch, not reaching restrictive barrier (PROCEDURE), Experimental: Interventional Group- OMM- Muscle energy (PROCEDURE).
Who is sponsoring clinical trial NCT05884944?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05884944 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Explore more on PlainTrial
Parkinson Disease
All registered trials for this condition
Osteopathy in Diseases Classified Elsewhere
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.